Michelle Welch+FollowGame-Changer for Lung Cancer FightersBig news for anyone battling advanced lung cancer: Datroway just got FDA approval as a new targeted treatment for people with EGFR-mutated non-small cell lung cancer (NSCLC) who’ve already tried other therapies. This drug acts like a smart missile, homing in on cancer cells and sparing more healthy ones. In trials, nearly half of patients saw their tumors shrink! If you or someone you know is running out of options, this could be a real breakthrough. Definitely worth asking your doctor about. #Health #BodyHealth #LungCancer80Share
Michelle Welch+FollowNew Hope for Rare Lung CancerBig news for anyone following cancer breakthroughs: the FDA just approved IBTROZI, a next-gen oral drug for advanced ROS1-positive non-small cell lung cancer. This rare type mostly hits younger, non-smokers and often spreads to the brain. IBTROZI showed super high response rates—even for those with brain metastases—and is generally well tolerated. With this approval, patients finally have a promising new option that could really change the game! #LungCancer #FDAApproval #CancerResearch #Health #BodyHealth50Share
wilsonjames+FollowNew Lung Cancer Pill Gets FDA Green LightBig news for lung cancer treatment! The FDA just approved Nuvation Bio’s new once-a-day pill, Ibtrozi, for people with ROS1-positive non-small cell lung cancer. This is a rare type, but the new drug could be a game-changer for those who need more options. Love seeing progress like this in cancer care! #LungCancer #FDAApproval #CancerResearch #Health #BodyHealth513Share
shermandarlene+FollowLung Cancer Breakthroughs You Need to KnowMajor news for small cell lung cancer: new immunotherapy combos are giving patients real hope for the first time in years! Adding the chemo drug lignin to atezolizumab can give patients three extra months without cancer getting worse. Even more exciting, a new drug called Imdelltra is helping people live over a year—way up from the usual 6-9 months. Plus, these new treatments come with fewer nasty side effects, and more patients (even those with brain mets) can join clinical trials. The future is looking brighter! #LungCancer #Immunotherapy #CancerResearch #Health140Share
Aaron Rodriguez+FollowLung Cancer Drug Shrinks Tumors Fast!Big news for lung cancer treatment: Tagrisso (osimertinib) is showing way more tumor shrinkage before surgery than chemo alone for patients with EGFR mutations. In a new study, about 1 in 4 patients saw major tumor reduction with Tagrisso (either solo or with chemo), compared to just 2% with chemo alone. This could mean better outcomes and more hope for early-stage lung cancer patients. Definitely a game-changer to ask your doctor about if you or someone you know is facing this diagnosis! #LungCancer #CancerResearch #Tagrisso #Health894Share
Michelle Welch+FollowGame-Changer for Lung Cancer?Big news in cancer treatment: Amgen’s new drug Imdelltra just cut the risk of death by 40% for small cell lung cancer patients compared to regular chemo! Patients lived over 5 months longer on average, and had fewer serious side effects (27% vs 62%). Plus, people felt better—less coughing and shortness of breath. These results could lock in FDA approval for Imdelltra. Feels like a huge win for patients and families facing this tough diagnosis. #LungCancer #MedicalBreakthrough #CancerResearch #Health10Share
Joseph Bradley+FollowAI Predicts Lung Cancer Years Ahead?!Imagine getting a single chest scan and knowing your lung cancer risk for the next six years—no matter if you’ve ever smoked! That’s what this new AI model, Sybil, can do. It’s a game-changer for early detection, especially in Asia where lung cancer is rising among non-smokers. Sybil could help docs personalize who needs more screening (and who doesn’t), so fewer unnecessary scans and more lives saved. Wild, right? #LungCancer #AIHealth #EarlyDetection #HealthTech #MedicalInnovation #Health10Share
Jacqueline Howard DDS+FollowNew Hope for Tough Lung Cancer CasesBig news for anyone following cancer breakthroughs: the FDA just approved Emrelis, a new treatment for hard-to-treat lung cancer that targets tumors with too much c-Met protein. It’s a game-changer for folks whose cancer didn’t budge with standard therapies. Bonus: there’s a new test to see if you qualify. Early trial results look promising, but more studies are on the way. Heads up—there are some side effects, so talk to your doc if you’re interested! #LungCancer #FDAApproval #CancerResearch #HealthNews #Health784Share
john24+FollowWould You Spot This Weird Nail Symptom?Ever heard of 'finger clubbing'? Brian Gemmell, a fitness instructor, only noticed his fingertips swelling—no cough, no breathlessness. Turns out, it was his only sign of lung cancer. He’s urging everyone: if you see something off (even if it seems random), get it checked! There’s even a simple test: press your fingernails together—if you can’t see a diamond-shaped gap, it could be a red flag. Early checks can literally save your life. Wild, right? #HealthAwareness #LungCancer #CheckYourNails #EarlyDetection #Wellness #Health244Share
